Tag Archives: MD

Drug Shows Potential for Treating Duchenne’s Muscular Dystrophy

An experimental drug called eteplirsen has shown potential as a treatment for Duchenne’s Muscular Dystrophy (DMD), Sarepta Therapeutics, Inc. announced today. The drug, which so far has shown no serious side effects, enabled boys to walk longer than those who received placebo. Most significantly, eteplirsen was shown not only to help in maintaining current muscle mass, but also in repairing damaged muscle.

Posted in News | Tagged , , , , | Leave a comment